Drug resistance in leprosy: lessons from past and future perspective
Gupta, U.D.; Katoch, V.M.
Indian Journal of Leprosy 71(4): 451-463
1999
ISSN/ISBN: 0254-9395 PMID: 10804973 Document Number: 500495
Some recent studies indicate that the problem of drug resistance in leprosy is very much there but the exact picture is not clear. In the emerging scenario with increasing number of new cases with low bacterial load, the conventional in-vivo and most of current in-vitro methods for determination of drug resistance may not help. It is pointed out that newer molecular approaches may be more useful and that it will be important to undertake studies to develop such tools.
Document emailed within 1 workday
Related Documents
Delarue, N.C. 1980: 1980 Gallie Memorial Lecture. Lung cancer in historical perspective: lessons from the past, implications of present experience, challenges for the future Canadian Journal of Surgery. Journal Canadien de Chirurgie 23(6): 549-557Anderson, T.J.C.; Roper, C. 2005: The origins and spread of antimalarial drug resistance: lessons for policy makers Acta Tropica 94(3): 269-280
Baquillon, G.; Ferracci, C.; Diallo, J.; Saint-Andreé, P.; Pattyn, S.R. 1981: Clinical and paraclinical aspects of secondary drug resistance to 4-4' diaminodiphenylsulfone in a population of leprosy patients in Bamako, Republic of Mali Acta Leprologica 85: 40-52
Eyckmans, L. 1990: Drug resistance of Plasmodium falciparum. Consequences and future prospects Presse Medicale 19(1): 9-10
Hashimoto, H.; Ohkubo, T. 1984: Drug resistance of bacteria--the current status and future prospect. 2. Staphylococcus Nihon Rinsho. Japanese Journal of Clinical Medicine 42(3): 658-663
Springer, S.A.; Larney, S.; Alam-Mehrjerdi, Z.; Altice, F.L.; Metzger, D.; Shoptaw, S. 2015: Drug Treatment as HIV Prevention Among Women and Girls Who Inject Drugs From a Global Perspective: Progress, Gaps, and Future Directions Journal of Acquired Immune Deficiency Syndromes 69 Suppl. 2: S155-S161
Pillay, D.; Albert, J.; Bertagnolio, S.; Boucher, C.; Brun-Vezinet, F.; Clotet, B.; Giaquinto, C.; Perno, C.F. 2013: Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network Antiviral Therapy 18(6): 831-836
Hamers, R.L.; Schuurman, R.; Sigaloff, K.C.E.; Wallis, C.L.; Kityo, C.; Siwale, M.; Mandaliya, K.; Ive, P.; Botes, M.E.; Wellington, M.; Osibogun, A.; Wit, F.W.; van Vugt, M.èl.; Stevens, W.S.; de Wit, T.F.R. 2012: Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study LANCET. Infectious Diseases 12(4): 307-317
Choy, B.K.; McClarty, G.A.; Chan, A.K.; Thelander, L.; Wright, J.A. 1988: Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations Cancer Research 48(8): 2029-2035
Hauzeur, A.C. 1960: Towards the eradication of leprosy ? Influence of ambulatory treatment of leprosy with DADPS, on the progression of the leprosy epidemic and its results Additional note concerning the existent reports between leprosy and allergy to tuberculin and the prophylactic value of BCG Ann Soc Beige Med Trop: 115-167
Hauzeur, A.C. 1960: Towards the eradication of leprosy ? Influence of ambulatory treatment of leprosy with DADPS, on the progression of the leprosy epidemic and its results Additional note concerning the existent reports between leprosy and allergy to tuberculin and the prophylactic value of BCG Ann Soc Beige Med Trop: 115-167
Bertagnolio, S.; Rodriguez-Diaz, R.A.; Fuentes-Romero, L.L.; Bennett, D.E.; Viveros-Rogel, M.; Hart, S.; Pilon, R.; Sandstrom, P.; Soto-Ramirez, L.E. 2012: Transmitted HIV drug resistance among drug-naive subjects recently infected with HIV in Mexico City: a World Health Organization survey to classify resistance and to field test two alternative patient enrollment methods Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 54(Suppl 4): S328-S333
Pannikar, V.K.; Daumerie, D. 2003: Reaching the underserved: lessons learnt from leprosy Indian Journal of Public Health 47(4): 154-159
Reid, S.E.; Reid, C.A.; Vermund, S.H. 2004: Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy International Journal of Std and Aids 15(11): 713-716
Bloom, B.R. 1986: Learning from leprosy: a perspective on immunology and the Third World Journal of Immunology 137(1): I-X
Martiniuk, F.; Giovinazzo, J.; Tan, A.U.; Shahidullah, R.; Haslett, P.; Kaplan, G.; Levis, W.R. 2012: Lessons of leprosy: the emergence of TH17 cytokines during type II reactions (ENL) is teaching us about T-cell plasticity Journal of Drugs in Dermatology: Jdd 11(5): 626-630
Payrow Shabani, O.A. 2007: Cosmopolitan justice and immigration : A critical theory perspective : Cosmopolitanism: Between past and future - Justice cosmopolite et immigration : Une perspective de la théorie critique : Cosmopolitisme : Entre passé et avenir European Journal of Social Theory 10(1): 87-98
Haggerty, R.J. 1978: Fit for the future: lessons for the United States Pediatrics 61(5): 804-806
Gershon, W. 1974: An approach to urban leprosy control. The Greater Madras Leprosy Treatment and Health Education Scheme (Greamaltes) sponsored by the German Leprosy Relief Association Leprosy Review 45(3): 211-217
Gershon, W. 1974: An approach to urban leprosy control. The Greater Madras Leprosy Treatment and Health Education Scheme (Greamaltes) sponsored by the German Leprosy Relief Association Leprosy Review 45(3): 211-217